Company news

Immunocore Holdings PLC news in 2026

Immunocore Holdings PLC's news releases, calls and decks from 2026, newest first.

View company

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

October 15, 2026

Decks in 2026